PLOS ONE
RESEARCH ARTICLE
Fast-onset effects of Pseudospondias
microcarpa (A. Rich) Engl. (Anacardiaceae)
hydroethanolic leaf extract on behavioral
alterations induced by chronic mild stress in
mice
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Adongo DW, Mante PK, Kukuia KKE,
Benneh CK, Biney RP, Boakye-Gyasi E, et al. (2023)
Fast-onset effects of Pseudospondias microcarpa
(A. Rich) Engl. (Anacardiaceae) hydroethanolic leaf
extract on behavioral alterations induced by
chronic mild stress in mice. PLoS ONE 18(2):
e0278231. https://doi.org/10.1371/journal.
pone.0278231
Editor: Bruno Giros, McGill University Department
of Psychiatry, CANADA
Received: January 7, 2022
Accepted: November 10, 2022
Published: February 2, 2023
Copyright: © 2023 Adongo et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the manuscript and its Supporting
information files.
Funding: The authors received no specific funding
for this work.
Competing interests: The authors have declared
that no competing interests exist.
Donatus Wewura Adongo ID1*, Priscilla Kolibea Mante2☯, Kennedy Kwami
Edem Kukuia3☯, Charles Kwaku Benneh1☯, Robert Peter Biney4☯, Eric Boakye-Gyasi2‡,
Hilda Amekyeh5‡, Benjamin Kingsley Harley ID6‡, Augustine Tandoh ID1‡, Prince
Dagadu Okyere2‡, Eric Woode1☯
1 Department of Pharmacology and Toxicology, School of Pharmacy, University of Health and Allied
Sciences, Ho, Ghana, 2 Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences,
College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana,
3 Department of Medical Pharmacology, University of Ghana Medical School, College of Health Sciences,
University of Ghana, Korle Bu, Accra, Ghana, 4 Department of Pharmacology, School of Pharmacy and
Pharmaceutical Sciences, University of Cape Coast, Cape Coast, Ghana, 5 Department of Pharmaceutics,
School of Pharmacy, University of Health and Allied Sciences, Ho, Ghana, 6 Department of Pharmacognosy
and Herbal Medicine, School of Pharmacy, University of Health and Allied Sciences, Ho, Ghana
☯ These authors contributed equally to this work.
‡ EBG, HA, BKH, AT and PDO also contributed equally to this work.
* dadongo@uhas.edu.gh
Abstract
Introduction
Pseudospondias microcarpa (Anacardiaceae) is a plant widely used traditionally for treating
various central nervous system disorders. A previous study in our laboratory confirmed that
the hydroethanolic leaf extract (PME) of the plant produces an antidepressant-like effect in
rodent models of behavioral despair. However, its effect on depressive-like behavior
induced by chronic mild stress (CMS) and its time course of action are still unknown. In this
context, the long-term effects of PME on cognitive function and depressive- and anxiety-like
behavior caused by CMS were assessed.
Methods
Male ICR mice were exposed to CMS for nine weeks and anhedonia was evaluated by monitoring sucrose intake (SIT) weekly. PME (30, 100, or 300 mg kg-1) or fluoxetine (FLX) (3,
10, or 30 mg kg-1) was administered to the mice during the last six weeks of CMS. Behavioral tests—coat state, splash test, forced swimming test (FST), tail suspension test (TST),
elevated plus maze (EPM), open field test (OFT), novelty suppressed feeding (NSF), EPM
transfer latency, and Morris water maze (MWM)—were performed after the nine-week CMS
period.
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
1 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
Results
When the mice were exposed to CMS, their SIT and grooming behavior reduced (splash
test), their coat status was poor, they became more immobile (FST and TST), more anxious
(OFT, EPM, and NSF), and their cognitive function was compromised (EPM transfer latency
and MWM tests). Chronic PME treatment, however, was able to counteract these effects.
Additionally, following two (2) weeks of treatment, PME significantly boosted SIT in stressed
mice (30 mg kg-1, P<0.05; 100 mg kg-1, P<0.05; and 300 mg kg-1, P<0.001), as compared to
four (4) weeks of treatment with FLX.
Conclusion
The present findings demonstrate that PME produces a rapid and sustained antidepressant-like action and reverses behavioral changes induced by chronic exposure to mild
stressors.
Introduction
Depression is a chronic mental illness primarily distinguished by gloomy mood and anhedonia; it is frequently accompanied by sleep problems, low self-esteem, guilty feelings, and suicide thoughts. Depression has significant direct and indirect costs for patients, their families,
and society in addition to its direct impacts on health [1, 2]. In recent years, there has been
mounting research that connects cognitive decline, anxiety, and depression [3, 4]. Cognitive
impairment in depression affects a variety of cognitive functions, such as executive function,
attention, memory, and psychomotor speed [3, 5]. The substantial co-morbidity between
mood and anxiety disorders, as well as the intriguing overlap between the affective alterations
seen in depression and anxiety disorders, point to a shared psychopathological pathway that
may explain these changes [6].
The greatest environmental risk factor linked to the development of depression is stress
exposure [7]. It has been established that exposure to stress, together with certain genetic risk
factors, increases susceptibility to depression [8]. Some of the environmental elements that
lead to the development of depressive disorders in humans have been hypothesized to be modeled by chronic mild stress (CMS) in mice [9, 10]. The CMS model simulates anhedonia,
which is a primary symptom of depression and the distinguishing characteristic of melancholia. Anhedonia is a reduced ability to perceive pleasure [11]. The CMS model is predicated on
the two hypotheses that sucrose solution consumption is a reliable indicator of reward sensitivity and that CMS has a generalized impact on reward sensitivity rather than having a specialized impact on responses to sweet tastes [12]. In the CMS paradigm, rats [13, 14] or mice [15,
16] are subjected to a variety of moderate stressors that change every few hours over the course
of several weeks or months, such as overnight illumination, periods of food and/or water deprivation, cage tilt, and grouped housing. In repeated studies, it is common to note a decrease in
the consumption and/or preference for a palatable mild (1–2%) sucrose solution as a measure
of this procedure’s efficacy [17].
Several drugs have been shown to be effective in reversing CMS-induced anhedonia in
rodents. These include tricyclic antidepressants [18, 19], selective serotonin reuptake inhibitors [1, 20], maprotiline, a particular inhibitor of noradrenaline reuptake [21], and moclobemide and brofaromine, inhibitors of monoamine oxidase [22, 23]. Chlordiazepoxide [21], d-
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
2 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
amphetamine [23], and the neuroleptic agents chlorprothixene and haloperidol [23], on the
other hand, were found to be ineffective in the CMS model. The aforementioned data thus
implies that the CMS model only responds to antidepressant therapies.
Herbal medicines, with their high safety margins, have proven to be effective in the treatment of depression [24, 25]. Moreover, various reports have shown that drugs from plant
sources are effective against the CMS model of depression [26, 27].
Pseudospondias microcarpa is one of such plants with medicinal properties. It is used as a
sedative and for treating general central nervous system disorders [28]. In the forced swimming test (FST) and tail suspension test (TST), we have previously demonstrated that the
hydroethanolic leaf extract of the plant (PME) exerts antidepressant-like effects by interacting with the 5-HT system, nitric oxide pathway, and the glycine/N-methyl-D-aspartate
(NMDA) receptor complex [29]. Additionally, it produces a rapid and sustained antidepressant-like effect in the repeated open-space swim model while improving cognitive function
[30].
In the current study, we use the CMS paradigm, a paradigm with greater face and construct
validity for clinical depression, to confirm in mice the great potential of PME in preventing or
managing depression. Additionally, we evaluate the effect of PME on depression-related cognitive impairment and co-morbid anxiety.
Materials and methods
Plant collection and extract preparation
Fresh P. microcarpa leaves were obtained at the Kwame Nkrumah University of Science and
Technology (KNUST) campus in Kumasi, Ghana (6˚ 40.626’N, 1˚ 34.041’W), and they were
authenticated at the Department of Herbal Medicine, Faculty of Pharmacy and Pharmaceutical
Sciences, KNUST, Kumasi. The plant’s leaves were ground into a fine powder after being air
dried for seven days. Over the course of 72 hours, the powder was cold percolated with 70%
(v/v) ethanol in water. The resulting extract was then condensed into a syrupy mass under
reduced pressure at 60˚C in a rotary evaporator. It was then preserved in a refrigerator for
usage after being further dried for a week at 50˚C in a hot air oven. The yield was 20.5% (w/w).
In this study, the crude extract is referred to as PME or extract.
Fourier-transform infrared spectroscopy (FT-IR) analysis of crude extract
To characterize the extract and identify the possible functional groups that may be present in
the sample, triplicate FT-IR (PerkinElmer UATR Two) spectra over a range of 400–4000 cm−1
were generated and the baseline corrected. This spectral region is unique for every compound/
compound mixture and hence can be used for identification and quality control of the extract
used in this study.
Animals
Male ICR mice (weighing 20–25 g, aged 8 weeks) were bought from the Noguchi Memorial
Institute for Medical Research in Accra, Ghana, and housed in an animal facility at the
Department of Pharmacology at KNUST in Kumasi, Ghana. The animals were kept in
groups of five in cages made of stainless steel that measured 34 cm by 47 cm by 18 cm. Soft
wood shavings were used as bedding, and the animals were kept in cages under controlled
conditions that included a 12/12-hour light-dark cycle (light cycle: 06:00 to 18:00, dark cycle:
18:00–06:00) and a temperature of 24 to 25˚C. All mice had free access to food (commercial
pellet diet; Agricare, Kumasi, Ghana) and water. A period of two weeks was allowed for
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
3 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
acclimatization to the laboratory environment. All laboratory procedures were conducted in
accordance with accepted principles for laboratory animal use and care [31]. The Faculty
Ethics Committee, Faculty of Pharmacy and Pharmaceutical Sciences, KNUST, gave its
approval for the study.
Test drug solutions
Fluoxetine hydrochloride (Prozac1, FLX) was purchased from Eli Lilly and Company Ltd.
(Basingstoke, England). Test samples were freshly prepared every day in saline (NaCl, 0.9%)
and administered p.o. in a volume of 10 mL kg-1 at the doses stated. Vehicle or control animals
received 0.9% saline in a volume of 10 mL kg-1. Administration of test compounds was done
via an oral gavage.
CMS and sucrose intake (SIT)
The CMS protocol used in this study was adopted from the procedure described by Papp,
Gruca (18). Mice were housed individually in small cages (8 cm × 13.5 cm × 8 cm) and trained
for two weeks to consume a palatable sucrose solution contained in 150 mL water bottles
placed above the cages. A 14-hour period of no food or water was followed by six 1-hour tests
in which 1% sucrose in water was made available. At the conclusion of each test, SIT was determined by weighing the pre-weighed bottles containing the solution and calculating the change
in weights. Testing began at 10:00 am.
The animals were randomly split into two matched groups (CMS and non-stressed [NS]
groups) after the last baseline test, and were housed individually as previously mentioned in
two different rooms. Subsequently, SIT was similarly measured at weekly intervals for the
duration of the experiment.
The CMS group of animals was subjected to the CMS procedure. A breakdown of the stress
regimen for each week is as follows: two periods of deprivation of food or water, two periods
of 45˚ cage tilt, two periods of intermittent illumination (lights on and off every 2 h), two periods in a soiled cage (250 mL water in sawdust bedding), two periods of paired housing, two
periods of low-intensity stroboscopic illumination (150 flashes/min), and two periods of no
stress. According to the schedule shown in Fig 1, each stressor was used for 10 to 14 hours,
continuously, day and night.
The other group representing NS animals was housed in a separate room and had no contact with the stressed animals. They were only deprived of food and water for 14 h before each
sucrose test.
Both CMS (stressed) and NS animals were then separated into matched subgroups (n = 8
mice per group) based on SIT after the initial three weeks of stress. For the subsequent six
weeks, they received daily oral administration of normal saline (10 mL kg-1), PME (30, 100, or
300 mg kg-1), or FLX (3, 10, or 30 mg kg-1) at 10:00 am.
Groupings were as follows:
NS groups: non-stressed control, PME (30, 100, or 300 mg kg-1), and FLX (3, 10, or 30 mg kg-1).
CMS groups: CMS control, PME (30, 100, or 300 mg kg-1), and FLX (3, 10, or 30 mg kg-1).
Weight variation
Before and during the unpredictable CMS periods, the body weights of the animals were
recorded every Monday at 8:00 am.
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
4 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
Fig 1. Schematic diagram showing the experimental design of the chronic mild stress (CMS) procedure.
https://doi.org/10.1371/journal.pone.0278231.g001
Behavioral assessments
Following the CMS procedure (that is, after week 6 of treatment), a number of behavioral tests
were conducted to evaluate depression (TST, FST, splash test, coat state assessment), anxiety
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
5 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
(elevated plus maze [EPM], novelty suppressed feeding [NSF], open field test [OFT]), and cognitive function (Morris water maze [MWM] task, and EPM transfer latency test). Tests were
performed in the following order over 3 weeks: coat state assessment (day 1), splash test (day
2), TST (day 4), FST (day 6), OFT (day 8), NSF (day 11), MWM task (days 13−18), and EPM
transfer latency (days 20 and 21). Tests were performed from 9:00 am to 1:00 pm and no stressors were applied before each test.
Coat state assessment. Each animal was carefully removed from its home cage for this
test, and a blinded experimenter examined and methodically recorded the condition of the
coat at eight different body parts, including the head, neck, forepaws, dorsal and ventral
regions, hind legs, tail, and genital region [32]. For each body area, a score of 0 was given for a
coat in good form, and a score of 1 for a dirty or disheveled coat. The total score for all the
body areas assessed was calculated and used as the final score.
Splash test. To analyze the grooming behaviors of both stressed and NS mice, this test
was run a day following the coat state assessment. Mice were splashed with a 10% sucrose solution in their home cages, and for five minutes, the animals were videotaped. The frequency of
grooming was calculated as the total number of licks during the 5-minute interval. Nose/face
grooming (strokes along the snout), head washing (semi-circular movements over the top of
the head and behind the ears), and body grooming (body fur licking) were among the grooming episodes that were observed [33].
Tail suspension test. This test was performed based on the method described by Steru,
Chermat [34]. Briefly, each mouse was separately suspended by the tail from a horizontal ringstand bar 50 cm above the floor using adhesive tape positioned 1 cm from the tip of the tail.
The posture of the mice was such that the horizontal plane was parallel to the base of their
tails. A 6-minute videotape was made of each test session. The final four minutes of the sixminute period’s behaviors were then analyzed with a public domain software JWatcher, version 1.0 (University of California, Los Angeles, USA, and Macquarie University, Sydney, Australia) for mobility and immobility durations. A mouse was considered to be immobile when it
stopped struggling and remained suspended on the horizontal bar.
Forced swim test. This experiment was performed according to the procedure described
by Porsolt, Bertin [35] with modifications. Briefly, mice were forced to swim for 6 min in polypropylene cylinders with a 10 cm diameter and a height of 25 cm that contained 10 cm of
water at 25˚C. Using a camcorder, the final four minutes of the six-minute test session were
recorded, and the duration of immobility—which represents the condition of depression—was
examined as previously reported for the TST. When a mouse ceased actively moving to stay
afloat and keep its head above water, it was regarded as immobile.
Open field test. This test was performed in control and CMS mice to study exploratory
and anxiety behavior [36]. The open field apparatus used consisted of a white Plexiglas box (50
cm × 50 cm × 20 cm) with its floor divided into 16 squares with black lines. The center was
designated as four squares, and the periphery as 12 squares along the walls. A 45 W low intensity diffuse light was used to illuminate the equipment from 45 cm above the ground. The
experiment was conducted in a darkened room with the exception of the open field. The animals were each placed in the center square and observed for five minutes. Then, videotaping
and later analysis were done on the center activity (number and duration of entries into the
central squares with all four paws) and number and duration of rearing (animal standing
upright on its hind limbs). The device was cleaned with 5% alcohol in between tests.
Elevated plus maze test. This test assesses unconditioned anxiety-like behavior in rats
and mice [37]. The EPM consisted of two open arms (30 cm × 5 cm), two enclosed arms (30
cm × 5 cm), and a connecting central platform (5 cm × 5 cm). The maze was elevated 38.5 cm
above the ground. Each mouse was positioned in the central neutral zone, facing one of the
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
6 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
close arms, at the start of the five-minute session, and their behavior was recorded on camera.
The videos were then scored based on behavioral indicators such as the number of entries and
the time spent in the open arms using the public domain software JWatcher™. An arm entry
was defined as a mouse having entered an arm of the maze with all four legs.
Novelty suppressed feeding test. The test was carried out during a 5-min period as previously described [38]. The testing device was a plastic box (50 cm x 50 cm x 20 cm) with 2 cm of
wooden bedding covering the bottom. The animals were denied access to any food in the
home cage for the previous twenty-four hours before behavioral testing. During testing, a solitary food pellet was put on a white paper platform that was positioned in the middle of the
box. The test began after the animal was placed in a corner of the box. The latency to feed (the
length of time before mice began to eat) was manually tracked.
Morris water maze test. Additionally assessed were the impacts of mouse behavior on
hippocampal-dependent spatial learning and memory via the MWM task [39]. The MWM
apparatus was a tank with dimensions of 120 cm in diameter and 60 cm in height, filled
with water to a depth of 45 cm, and kept at a temperature of 23±1˚C. In order to make the
water opaque, non-toxic black ink was added. By two imaginary perpendicular lines crossing the middle of the tank, the tank was divided into four equal quadrants (NE, SE, NW,
and SW). To allow a mouse to quickly climb and escape from the water, a moveable, circular, black platform with a diameter of 5 cm was positioned in the center of the SW quadrant
(the target quadrant) and lowered 2 cm below the water’s surface. Each session was
recorded with a video camera approximately 100 cm above the center of the maze. The
environment was kept lightless to maintain visual extra-maze cues and minimize noise
disturbance.
Place navigation and a spatial probe trial made up the MWM task. Animals in the place
navigation test underwent four training trials lasting two minutes each over the course of
five days. It assessed motivation and ability to swim and escape from the aversive situation of
being placed in the water by associating the platform with escape. The platform was in the
middle of the SW quadrant for each trial. Every time, the mouse entered the pool facing the
wall from a different starting position, altering the straight path to the platform. Briefly, the
location of the platform remained constant and mice were allowed to swim for 60 s or until
they located the platform. Mice were manually led to the platform after failing to find it
within 60 seconds, where they remained for at least 5 seconds before being returned back to
their cage.
Mice underwent the probe trial in which the platform was removed 24 hours following the
final training trial of the escape acquisition test. The time spent in the target quadrant, or the
quadrant where the platform was throughout the training sessions, was calculated as a measure
of spatial memory during the 60-second probing trial.
EPM transfer latency. The procedure for assessing learning and memory was performed
as previously described [40, 41]. Evaluating learning and memory in mice was done using
the exteroceptive behavioral model (EPM), in which the stimulus was external to the body.
Each mouse was positioned at one end of the outstretched arms on the first day, facing away
from the central platform. The amount of time a mouse needs to move into one of the closed
arms with all four of its legs is known as transfer latency. For each animal, this was noted on
the first day. Animals were gently pushed into one of the two closed arms and transfer
latency was calculated as 90 seconds if they did not enter one of the closed arms within that
time frame. Each mouse was allowed to explore the maze for another 2 min and returned to
its home cage. Retention of this learned task (memory) was examined 24 h after the first day
of trial.
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
7 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
Statistical analysis
A sample size of eight animals was used in all tests. All data are presented as mean ± standard
error of the mean (SEM). To compare differences between groups, one-way analysis of variance (ANOVA) was performed with Newman-Keuls test as post hoc. Two-way ANOVA with
Bonferroni’s post hoc test (treatment × dose) was also performed to compare the NS and CMS
groups. Time-course curves were subjected to two-way (treatment × time) repeated measures
ANOVA with Bonferroni’s post hoc test. All statistical evaluations were performed using
GraphPad Prism for Windows 5 (GraphPad Software, San Diego, CA, USA). Bonferroni’s test
or Newman-Keuls test of P values < 0.05 were regarded as statistically significant.
Results
FT-IR analysis
FT-IR spectroscopy was used for distinct functional group identification over an IR region of
400–4000 cm-1 (Fig 2). Characteristic spectra in the region were used as the fingerprint spectra
for subsequent comparison of extracts. Baseline corrected IR spectra and peak values are provided in the Supporting information.
Sucrose intake
From the initial baseline test, all animals drank approximately 1.68–3.72 g of sucrose solution
(data captured under supplementary materials). Exposure of mice to various stressors in the
CMS procedure for three weeks (week 0) resulted in a significant decrease in the consumption
of 1% sucrose solution as compared to the observation in the NS group (P<0.001). SIT by the
NS mice however remained at the same level (approximately 2.60 g). The difference between
NS and CMS animals treated with vehicle persisted at a similar level for the remainder of the
6-week treatment period (P<0.001).
Chronic treatment with PME and FLX had no significant effect on SIT in NS animals
(P<0.05). However, as shown in Fig 3a, PME increased sucrose consumption in the stressed
(CMS) animals, resulting in significant effects of treatment (F3,196 = 34.48, P<0.0001), interaction (F18,196 = 2.160, P = 0.0054), and time (F6,196 = 16.17, P<0.0001). Compared to week 0
scores, increases in SIT in stressed animals treated with PME reached statistical significance
after 2 weeks of treatment as shown in Fig 3a (30 mg kg-1, P<0.05; 100 mg kg-1, P<0.05; and
300 mg kg-1, P<0.001). This effect was maintained for the remainder of the treatment period.
Fig 2. Infrared spectrum of the hydroethanolic leaf extract of P. microcarpa (PME).
https://doi.org/10.1371/journal.pone.0278231.g002
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
8 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
Fig 3. SITs of NS and CMS mice treated with saline, PME (30–300 mg kg-1), or FLX (3–30 mg kg-1). Data are presented as time-course curves (a and
c) and as mean±SEM (n = 8) of the AUCs (b and d). Significantly different from CMS control: � P<0.05, �� P<0.01, ��� P<0.001 (Newman-Keuls’ post
hoc test for the AUC or two-way ANOVA followed by Bonferroni’s post hoc test for time-course curves). Statistically significant difference when CMS
and NS groups were compared: †††P<0.001 (two-way repeated measures ANOVA followed by Bonferroni’s post hoc test). ctrl, control.
https://doi.org/10.1371/journal.pone.0278231.g003
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
9 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
Furthermore, by week 3, sufficient recovery from the stress-induced deficit in sucrose consumption was observed as compared to the vehicle-treated control (NS) mice. Analysis of the
areas under the curves (AUCs) by one-way ANOVA demonstrated a significant increase in
SIT (F3,28 = 32.29, P<0.0001; Fig 3b) for PME, with the Newman-Keuls post hoc analysis giving
statistically significant data at all the doses tested (all P<0.001).
In the CMS animals, FLX (Fig 3c) increased sucrose consumption, resulting in significant
effects of treatment (F3,196 = 13.40, P<0.0001) and time (F6,196 = 13.98, P<0.0001). However,
unlike PME, the increased sucrose consumption in the stress animals reached significance
after 4 weeks of FLX treatment (P<0.05 in each instance). In analyzing the AUC for FLXtreated CMS animals, one-way ANOVA demonstrated a significant increase in SIT (F3,28 =
19.31, P<0.0001; Fig 3d) as compared to the data for the CMS control mice.
Weight change
Weight change in saline-control mice increased gradually until it peaked in the third week.
Mice subjected to the CMS paradigm for 3 weeks (week 0) showed a significant decrease in
weight change relative to the control (NS) group (P<0.001). Furthermore, the extract-treated
stressed animals showed a significant increase in body weight (F4,280 = 136.7, P<0.0001 as
compared to the CMS-saline group; Fig 4a), with the Bonferroni’s post hoc analysis showing
significant differences after weeks 2 and 3 for the 100 and 300 mg kg-1 doses, respectively
(P<0.05 in each case). FLX also increased weight change (F4,280 = 153.6, P<0.0001; Fig 4e) in
stressed mice, reaching a significantly different value after week 3 (P<0.001 for 10 mg kg-1 and
P<0.05 for 30 mg kg-1) and week 6 (P<0.01 for 3 mg kg-1).
Coat state
The coat states of both stressed and NS mice were scored nine weeks after the beginning of the
unpredictable CMS regimen. As shown in Fig 5, a significant difference in coat state was
observed between NS and CMS-control mice at the end of the unpredictable CMS regimen
(P<0.001). PME (F4,35 = 19.70, P<0.0001; Fig 5a) and FLX (F4,35 = 12.01, P<0.0001; Fig 5b)
significantly reversed the degradation of coat state induced by CMS in stressed mice. In addition, no significant difference in coat state was observed between NS mice treated with test
compounds and the NS-control group (P>0.05).
Splash test
Total grooming frequency showed a significant difference between NS control and stressedcontrol groups at the end of the unpredictable CMS regimen (P<0.05). Treatment of stressed
mice with PME (F4,35 = 3.145, P = 0.026; Fig 5c) and FLX (F4,35 = 2.891, P = 0.036; Fig 5d) significantly increased the total grooming frequency in the splash test when compared to the
CMS group. No significant difference was observed between drug-treated control mice and
the NS-control mice (P>0.05).
Tail suspension test
Mice with CMS-induced depression exhibited a significant increase in immobility duration as
compared to the control group (P<0.05). However, treatment with PME for six weeks significantly reversed the increased immobility time (F4,35 = 3.872, P = 0.010; Fig 6a) induced by
CMS. In the NS mice, PME significantly decreased immobility time as compared to the NS
group with Newman-Keuls post hoc analysis revealing a statistical significance at 300 mg kg-1
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
10 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
Fig 4. Effects of PME (30–300 mg kg-1) and FLX (3–30 mg kg-1) on weight change in NS and CMS mice. Data are
presented as time course curves (a, c, e, and g) and as mean±SEM (n = 8) of AUCs (b, d, f, and h). Significantly
different from stress-control group: � P<0.05, ��� P<0.001 (Newman-Keuls post hoc test for the AUCs or two-way
ANOVA followed by Bonferroni’s post hoc test for time-course curves). Significant difference when compared to NScontrol mice: †††P<0.001 (one-way ANOVA followed by Newman-Keuls’ post hoc test).
https://doi.org/10.1371/journal.pone.0278231.g004
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
11 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
Fig 5. Effects of PME (30–300 mg kg-1) and FLX (3–30 mg kg-1) on coat index (a and b) and total frequency grooming
frequency (c and d) in the coat state assessment and splash test, respectively. Data are expressed as group mean±SEM (n = 8).
Significantly different from CMS-control group: � P<0.05, �� P<0.01, ��� P<0.001 (one-way ANOVA followed by Newman-Keuls
post hoc test) and significant difference when CMS and NS groups were compared: †P<0.05, ††P<0.01, †††P<0.001 (two-way
repeated measures ANOVA followed by Bonferroni’s post hoc test). ctrl, control.
https://doi.org/10.1371/journal.pone.0278231.g005
(P<0.05). Immobility duration was also significantly decreased (F4,35 = 2.932, P = 0.0343; Fig
6b) by FLX in CMS mice when compared to the stressed-control group.
Forced swim test
Fig 6c and 6d shows the effects of PME and FLX on the duration of immobility in mice in the
FST. A significant increase in immobility time (P<0.01) was observed in mice subjected to
CMS; however, this was not observed in the NS control mice. Furthermore, chronic treatment
with PME (30, 100, or 300 mg kg-1; p.o.) significantly decreased immobility duration (F4,35 =
4.631, P = 0.0042) in all stressed mice. In addition, daily treatment with PME resulted in a significant decrease in immobility time in NS mice (P<0.05) at 300 mg kg-1 when compared to
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
12 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
Fig 6. Effects of PME (30–300 mg kg-1) and FLX (3–30 mg kg-1) on immobility time in NS and CMS mice in the TST (a and b) and FST (c and d).
Data are presented as mean±SEM (n = 8). Significantly different from CMS control: � P<0.05, �� P<0.01, ��� P<0.001 (one-way ANOVA followed by
Newman-Keuls test). Significant difference when CMS and NS groups were compared: †P<0.05, ††P<0.01 (two-way repeated measures ANOVA
followed by Bonferroni’s post hoc test). #P<0.05, ##P<0.01: compared to NS-control group. ctrl, control.
https://doi.org/10.1371/journal.pone.0278231.g006
the NS control group using post hoc analysis. The reference drug FLX (3, 10, or 30 mg kg-1; p.
o.) also significantly decreased immobility duration (F4,35 = 7.632, P = 0.0001) in CMS mice.
Open field test
In Table 1, the Newman-Keuls post hoc analysis showed that exposure of mice to the CMS paradigm resulted in decreased central ambulation (P<0.001) and rearing (P<0.001) when compared to the NS group. However, administration of PME to mice subjected to CMS resulted in
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
13 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
Table 1. Effects of PME and FLX on the behavior of NS and CMS mice in the OFT.
Dose (mg kg-1)
Groups
NS
CMS
PME (NS)
PME (CMS)
FLX (NS)
FLX (CMS)
CA/TA
Rearing Frequency
25.25±3.30���
Central Activity (CA)
122.3±10.25���
Total Activity (TA)
0.20±0.01��
22.75±1.82���
8.38±1.51
74.0±5.32
0.12±0.02
7.00±1.13
30
24.63±2.59���
115.4±6.04���
0.21±0.02��
19.75±2.22���
100
25.50±1.75
���
116.3±3.18
���
0.22±0.02
20.13±2.22���
300
26.63±3.01
���
119.4±4.42
���
0.22±0.03
22.88±1.89���
30
��
��
�
14.25±1.84 †
85.50±7.00
0.17±0.02
15.13±2.35�
100
15.25±2.54
�
87.50±13.71
0.19±0.04
19.00±4.21��
300
18.13±2.29
�
86.38±10.79
0.24±0.03
17.88±1.06��
3
24.00±4.42
���
112.50±11.28
0.21±0.03
18.88±2.72��
�
��
��
10
24.88±2.01���
114.10±4.99��
0.22±0.02��
19.63±3.02��
30
28.43±2.34���
129.00±10.33��
0.22±0.01��
23.57±2.82���
3
12.63±2.12††
84.50±11.60
0.15±0.02
17.13±4.16�
10
15.88±2.32
�
90.38±4.76
0.17±0.02
17.88±2.40�
30
18.88±2.62
�
88.13±16.69
0.24±0.03
17.00±3.30�
��
Key: NS, non-stressed; CMS, chronic mild stress; CA, central ambulation; TA, total activity
Data are expressed as group mean±SEM (n = 8). Significantly different from CMS group: � P<0.05, �� P<0.01, ��� P<0.001 (one-way ANOVA followed by NewmanKeuls test). Significant difference when CMS and NS groups were compared: †P<0.05, ††P<0.01 (two-way repeated measures ANOVA followed by Bonferroni’s post
hoc test).
https://doi.org/10.1371/journal.pone.0278231.t001
a significant reversal of the stress-induced behavioral alteration as observed by increases in
central ambulation (F4,35 = 6.73, P = 0.0004) and rearing (F4,35 = 6.012, P = 0.0009).
Daily administration of FLX resulted in higher central ambulation (F4,35 = 6.819,
P = 0.0004) and rearing (F4,35 = 4.278, P = 0.0064) in CMS mice as compared to the stressedcontrol group.
Total activity (number of crossings), which is a measure of exploratory behavior in the
OFT, was significantly decreased in the CMS mice (P<0.05; as compared to the NS-control
group). After six weeks of treatment with PME, post hoc analysis of the data obtained showed
no significant difference in total activity (P>0.05, compared to the CMS or NS control group).
Chronic treatment with FLX also had no effect on total activity (P>0.05).
With regards to the ratio of central ambulation to total activity, this was significantly
decreased in the CMS mice (P<0.01; as compared to the NS-control group). One-way
ANOVA showed that the ratio of central ambulation to total activity was significantly
increased in mice subjected to CMS after chronic administration of PME (F4,35 = 2.94,
P = 0.0340) or FLX (F4,35 = 4.57, P = 0.0045).
EPM and NSF tests
In the EPM test, mice exposed to CMS were more anxious than the control mice, as can be
observed by the decreases in % open arm entries and % time spent in open arms (Fig 7). This
anxiety-like behavior was however reversed by daily treatment with PME, which resulted in
significant increases in % open arm entries (F4,35 = 3.592, P = 0.014; Fig 7a) and % time spent
in open arms (F4,35 = 9.967, P = 0.010; Fig 7c). Newman-Keuls post hoc analysis also revealed
an anxiolytic-like activity among the PME-treated NS mice; this was evidenced by the statistically significant increases in % entries and % time spent in the open arms at 300 mg kg-1 (both
at P<0.05 as compared to the NS group).
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
14 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
Fig 7. Effects of PME (30–300 mg kg-1) and FLX (3–30 mg kg-1) in NS and CMS-exposed mice on % open arm
entries (a and b), % time spent in open arms (c and d) in the EPM test and latency to feed (e and f) in the NSF
paradigm. Data are presented as mean±SEM (n = 8). Significantly different from CMS control: � P<0.05, �� P<0.01,
���
P<0.001 (one-way ANOVA followed by Newman-Keuls’ post hoc test). Significantly different from NS control:
#P<0.05, ###P<0.001 (one-way ANOVA followed by Newman-Keuls’ post hoc test). Significantly different when CMS
and NS groups were compared: †P<0.05, ††P<0.01, †††P<0.001 (two-way repeated measures ANOVA followed by
Bonferroni’s post hoc test). ctrl, control.
https://doi.org/10.1371/journal.pone.0278231.g007
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
15 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
FLX induced similar results in the CMS mice as PME did [% open arm entries (F4,35 =
3.554, P = 0.015; Fig 7b) and % time spent in open arms (F4,35 = 9.497, P = 0.0003; Fig 7d)].
Chronic administration of FLX to NS mice also resulted in an anxiolytic-like effect as compared to the saline control group [% open arm entries (F4,34 = 9.923, P<0.0001) and % time
spent in open arms (F4,34 = 24.31, P<0.0001)].
In the NSF test, exposure of mice to CMS significantly prolonged feeding latency (P<0.05
compared to NS control), whereas chronic treatment with either PME (F4,35 = 3.42, P = 0.018;
Fig 7e) or FLX (F4,35 = 3.024, P = 0.030; Fig 7f) significantly decreased latency to feed in the
novel arena.
Morris water maze test
This test was performed to assess spatial learning and memory in the mice. As the number of
trial days progressed, mice exposed to CMS showed increased escape latency (decreased learning behavior) as compared to the NS control group; this increase was statistically significant on
the third day (P<0.05). However, PME and FLX attenuated the learning deficit induced by
CMS. None of the mice showed significant changes in escape latency during the first day as
compared to the CMS control group (P>0.05).
Change in escape latency decreased significantly in all drug-treated stressed mice following
the training sessions, indicating that all mice showed some degree of learning [PME: F4,209 =
11.31, P<0.0001 (Fig 8a) and FLX: F4,209 = 12.72, P<0.0001 (Fig 8e); two-way ANOVA
(treatment × time)]. Moreover, a post hoc analysis revealed significant difference in data from
the third trial for all treated groups (P<0.05), which confirms good learning in mice exposed
to various stressors. One-way ANOVA revealed a significant decrease in the change in escape
latency following treatment with PME (F4,35 = 6.693, P = 0.0004; Fig 8b) and FLX (F4,35 =
5.898, P = 0.001; Fig 8f), which is indicative of an improvement in learning behavior.
The spatial probe trial test was performed 24 h after the last training session to assess memory retention. CMS mice showed impaired cognitive performance; this was evidenced by a significant decrease in preference for the target quadrant, where the platform was previously
placed during the training trials (P<0.01 compared to the NS control mice). Furthermore,
PME (F4,35 = 4.421, P = 0.0054) and FLX (F4,35 = 4.496, P = 0.0049) significantly increased the
percentage time spent in the target quadrant by the stressed mice, which is indicative of
improved memory (Fig 9). However, chronic treatment with PME and FLX did not affect spatial learning or memory in the NS animals (P>0.05 compared to NS control mice).
Elevated plus maze transfer latency
Mice with CMS-induced depression showed significant increase in transfer latency on day 1
(learning) in the EPM test (P<0.05 compared to the NS control group). However, PME (F4,35
= 2.907, P = 0.035; Fig 10a) and FLX (F4,35 = 3.136, P = 0.026; Fig 10b) significantly decreased
transfer latency in CMS mice. On day 2 (memory), the decreased transfer latency observed in
CMS mice was significantly reversed by treatment with PME (F4,35 = 3.181, P = 0.0249; Fig
10c) and FLX (F4,35 = 2.836, P = 0.038; Fig 10d).
Discussion
In this study, CMS consistently changed the behavioral profiles of the mice, including anhedonia (reduced SIT), depression (FST and TST), and anxiety (EPM, OFT, and NSF). In the
MWM task, cognitive deficits were also noted. However, PME restored these behavioral modifications, indicating that the extract may be able to guard against the harmful effects of chronic
depression.
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
16 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
Fig 8. Performances of NS and CMS mice after chronic treatment with PME (30–300 mg kg-1) or FLX (3–30 mg
kg-1) in the MWM test. Data are presented as time-course curves (a, c, e, and g) and as mean±SEM (n = 8) of AUCs
(b, d, f, and h). Significantly different from CMS control group: �� P<0.01, ��� P<0.001 (one-way ANOVA followed by
Newman-Keuls’ post hoc test). ctrl, control.
https://doi.org/10.1371/journal.pone.0278231.g008
For preclinical evaluation of antidepressants in animal models, chronic exposure to a variety of uncontrollable stimuli in an unpredictable way is well documented [13, 42]. Decreased
sucrose consumption (sweet food) induced by the CMS model has been demonstrated to represent anhedonia (the lack of interest or pleasure) in animals, which is one of the key symptoms necessary for identifying a major depression in humans [43]. Interestingly, PME was able
to reverse the anhedonic behavior induced by the CMS procedure. Anhedonia is a sign of
depression; therefore, it stands to reason that PME exerted an antidepressant-like effect. Similar results were observed for FLX. The findings of this study support prior findings that
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
17 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
Fig 9. Effects of PME (30–300 mg kg-1) and FLX (3–30 mg kg-1) on the % time spent in target quadrant by NS and CMS mice in the probe trial
test. Data are presented as mean±SEM (n = 8). Significantly different from CMS control: � P<0.05, �� P<0.01 (one-way ANOVA followed by NewmanKeuls test). Significant difference when CMS and NS groups were compared: ††P<0.01 (two-way repeated measures ANOVA followed by Bonferroni’s
post hoc test). ctrl, control.
https://doi.org/10.1371/journal.pone.0278231.g009
repeated exposure to minor stresses over time resulted in a significant decrease in the consumption of 1% sucrose solution. This deficit can be efficiently corrected by long-term but not
short-term usage of standard antidepressants [44].
According to numerous accounts, it normally takes 3–4 weeks of treatment to reverse
CMS-induced anhedonia, which is very similar to the clinical time course of the effects of different antidepressants. [1, 45]. The action of antidepressants in CMS is similar to their clinical
activity, with regards to their efficacy (full recovery at the end of treatment period) and specificity (lack of significant effects in NS animals) [12, 18]. Compared to the four weeks needed
with FLX, anhedonic behavior in stressed mice receiving PME was reversed during the first
two weeks of treatment. This suggests that PME will act more quickly than is often seen after
continuous dosing of conventional antidepressants. Additionally, the effects of PME lasted
during the entire duration of treatment. PME produced a comparable rapid-onset effects in
our prior investigation using the repeated open-space swim paradigm, which involved the
interaction of the extract with glycine/NMDA receptors, and this current study in CMS verifies
these results [30]. Additionally, the results are consistent with other research demonstrating
that glycine site NMDA antagonists had immediate antidepressant benefits in the CMS model
of chronic depression [46, 47].
Furthermore, PME reversed CMS-induced immobility in the FST and TST, supporting the
results of the weekly SIT tests, in which the extract greatly reduced anhedonia. To further confirm the antidepressant-like property of PME in CMS-induced depression, the coat state
assessment and splash tests were conducted. Mice that are consistently stressed out typically
have poor coat status, however antidepressant medications typically reverse this phenotype
[48, 49]. The splash test on the other hand is both a direct measure of grooming and an indirect evaluation of SIT [9]. As anticipated, the CMS regimen used in this study caused coat state
degradation and decreased grooming behavior in stressed mice during the splash test.
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
18 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
Fig 10. Performances of NS and CMS mice after chronic treatment with PME (30–300 mg kg-1) or FLX (3–30 mg kg-1) in the EPM transfer
latency test. Data are presented as mean±SEM (n = 8). Significantly different from CMS control: � P<0.05, �� P<0.01 (one-way ANOVA followed by
Newman-Keuls post hoc test). Significant difference when CMS and NS groups were compared: ††P<0.01 (two-way repeated measures ANOVA
followed by Bonferroni’s post hoc test). ctrl, control.
https://doi.org/10.1371/journal.pone.0278231.g010
However, PME treatment led to increased total grooming frequency and a better coat condition, which are signs of antidepressant-like activity. The findings of this investigation are consistent with previous studies in which antidepressants could prevent the impact of unexpected
CMS on coat state or the splash test [32, 50].
Signs of anxiety are often present in both depressed patients and animal models for screening antidepressants. Furthermore, many antidepressant drugs have anxiolytic properties [51,
52] and are now recommended as first-line treatment for several anxiety disorders. Several
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
19 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
studies have shown that exposure of mice to the CMS paradigm induces anxiety [36, 53]; therefore, the EPM, OFT, and NSF paradigms were performed to assess the impact of PME on
CMS-induced anxiety. The OFT is a conventional approach/avoidance paradigm in which
anxiety and exploration are simultaneously evoked by a novel setting [54]. An increase in
activity or time spent in the center of the open field indicates reduction in anxiety and/or
increase in exploration [55]. In this experiment, CMS mice repeatedly exposed to stressors
showed reduced activity, central entries, and rearing, which are signs of increased anxiety and
diminished exploration, which is consistent with other findings [56, 57]. However, PME
greatly increased central ambulation and rearing to counteract the altered open field behavior,
most likely as a result of its anxiolytic impact [58]. Furthermore, PME administration over an
extended period of time restored the CMS-induced reduction in locomotor activity. As compared to the extract, the common antidepressant FLX had similar effects. This discovery is in
line with other findings, which strongly imply that mice treated chronically with FLX have
reduced anxiety and/or increased exploration [55].
The EPM test is a popular paradigm that offers an impartial assessment of rodents’ anxietylike behavior (% of entry or time spent in the open arms) [59, 60]. Increased anxiety-like
behavior in this test has been observed after CMS induction [61, 62]. The open arms of the
EPM are naturally avoided by animals displaying anxiety-like behavior, and anxiolytic drugs
often increase open arm exploration [63, 64]. According to the current research, animals
exposed to CMS exhibit a marked reduction in the percentage of entries and duration spent in
the EPM’s open arms, which is suggestive of an anxious state. Chronic administration of PME
and FLX, however, markedly reduced this anxiogenic behavior, indicating an anxiolytic-like
effect. In a prior investigation, the anxiolytic-like effects of PME in the EPM were confirmed
[58].
The anxiolytic effect of PME was further evaluated in stressed and NS mice using the NSF
test.
This test evaluates hyponeophagia, which is the inhibition of feeding brought on by novelty
exposure. In a novel environment, anxiogenic treatments increase latency and decrease consumption while anxiolytics generally decrease latency and increase consumption [65]. In the
current investigation, CMS increased the anxiogenic effects on the mice, but PME decreased
the animals’ feeding latency (anxiolytic effect). According to earlier research, which shows that
long-term use of serotonin-based antidepressants is necessary for the production of anxiolytic
effects, reversal of the hyponeophagia caused by CMS can be accomplished by using PME [55,
66]. We have demonstrated previously that PME elicits its antidepressant-like effects via serotonergic mechanisms [29], hence, it is not surprising that it shows significant reduction in anxiety-related behaviors when tested in the three different approaches.
In humans, cognitive impairment and depression frequently coexist, and this association
between the two conditions is notable. Dementia and depression may interact in a number of
ways; for example, depression may be induced by cognitive decline, and dementia may also be
a symptom of depression [67, 68]. Therefore, in this chronic model of depression, the effects of
PME on cognitive performance in the MWM task were evaluated. Animals must employ additional maze cues to remember the position of a concealed platform in a pool of water in order
to complete the hippocampal-dependent spatial learning and memory challenge known as
MWM [69, 70]. Memory is time spent in the area of the platform during a test session in
which the platform has been removed, whereas learning is assessed as a decreased latency to
discover the hidden platform across sessions [71].
According to the results of this study, chronically subjecting mice to a variety of unpredictable stressors results in an increase in transfer latency and a decrease in quadrant dwell
time during the MWM task, providing clear evidence that CMS significantly degrades
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
20 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
hippocampal-dependent spatial learning and memory performance [1, 68]. The escape latencies in the drug-treated groups, however, steadily decreased as the number of training days
increased, and there was a noticeable improvement over the last three days. Additionally,
mouse performance in the probing trial, in which quadrant stay duration was considerably
longer in mice treated with the extract, served as a primary indicator of the permanence of spatial memory. The results of this study thus show that repeated PME treatment may be therapeutically efficient in treating memory impairment caused by chronic stress.
We additionally measured weight gain or loss since it is a common symptom of depression
[72, 73]. The current study demonstrated that CMS can significantly reduce mice’s body
weight. Chronic stress has been shown in the past to change the rate of weight gain, especially
in male rats [74, 75]. This reduction in weight gain is a reliable index of the stress experience
[56, 76]. However, prolonged PME treatment increased weight gain in the stressed mice without having an impact on the control animals.
Conclusion
The present study provides evidence that P. microcarpa leaf extract improves anhedonia, anxiety, and memory impairment induced by chronic exposure to mild stressors. Moreover, unlike
FLX, it exhibits a rapid and sustained antidepressant-like effect.
Supporting information
S1 Appendix. Peak table for IR spectra of the hydroethanolic leaf extract of P. microcarpa
(PME).
(TIF)
S2 Appendix. Baseline sucrose intake for mice (group 1).
(PDF)
S3 Appendix. Baseline sucrose intake for mice (group 2).
(PDF)
S4 Appendix. Sucrose intake for CMS mice after 3 weeks of baseline.
(PDF)
S5 Appendix. Sucrose intake for non-stressed after 3 weeks of baseline.
(PDF)
Acknowledgments
We are grateful to Messrs Thomas Ansah, Gordon Darku, Prosper Akortia, and Edmond Dery
of the Department of Pharmacology, Kwame Nkrumah University of Science and Technology
(KNUST) for their technical assistance.
Author Contributions
Conceptualization: Donatus Wewura Adongo, Priscilla Kolibea Mante, Eric Woode.
Data curation: Donatus Wewura Adongo, Kennedy Kwami Edem Kukuia, Charles Kwaku
Benneh, Robert Peter Biney, Eric Boakye-Gyasi, Hilda Amekyeh, Benjamin Kingsley Harley, Augustine Tandoh, Prince Dagadu Okyere.
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
21 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
Formal analysis: Donatus Wewura Adongo, Priscilla Kolibea Mante, Kennedy Kwami Edem
Kukuia, Charles Kwaku Benneh, Robert Peter Biney, Eric Boakye-Gyasi, Hilda Amekyeh,
Benjamin Kingsley Harley, Augustine Tandoh, Prince Dagadu Okyere, Eric Woode.
Investigation: Donatus Wewura Adongo, Kennedy Kwami Edem Kukuia, Charles Kwaku
Benneh, Robert Peter Biney, Eric Boakye-Gyasi, Hilda Amekyeh, Benjamin Kingsley Harley, Augustine Tandoh, Prince Dagadu Okyere.
Methodology: Donatus Wewura Adongo.
Supervision: Priscilla Kolibea Mante, Eric Woode.
Writing – original draft: Donatus Wewura Adongo.
Writing – review & editing: Donatus Wewura Adongo, Priscilla Kolibea Mante, Kennedy
Kwami Edem Kukuia, Charles Kwaku Benneh, Robert Peter Biney, Eric Boakye-Gyasi,
Hilda Amekyeh, Benjamin Kingsley Harley, Augustine Tandoh, Prince Dagadu Okyere,
Eric Woode.
References
1.
Elizalde N, Gil-Bea FJ, Ramı́rez MJ, Aisa B, Lasheras B, Rio J, et al. Long-lasting behavioral effects
and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment. Psychopharmacology. 2008; 199(1):1–14. https://doi.org/10.1007/s00213-007-1035-1 PMID:
18470507
2.
Takao Y, Figueroa E, Berna KFJ, Jo Y, Kissane LA, Yoshimura K, et al. Validation of a novel online
depression symptom severity rating scale: the R8 Depression. Health Qual Life Outcomes. 2021; 19
(1):163-. https://doi.org/10.1186/s12955-020-01654-z PMID: 34118932.
3.
Fu W, Xie H, Laudon M, Zhou S, Tian S, You Y. Piromelatine ameliorates memory deficits associated
with chronic mild stress-induced anhedonia in rats. Psychopharmacology. 2016; 233(12):2229–39.
https://doi.org/10.1007/s00213-016-4272-3 PMID: 27007604
4.
Mineka S, Anand D, Sumner JA. Important issues in understanding comorbidity between generalized
anxiety disorder and major depressive disorder. 2014.
5.
Bortolato B, Miskowiak KW, Köhler CA, Maes M, Fernandes BS, Berk M, et al. Cognitive remission: a
novel objective for the treatment of major depression? BMC medicine. 2016; 14(1):1–18. https://doi.org/
10.1186/s12916-016-0560-3 PMID: 26801406
6.
Groen RN, Ryan O, Wigman JTW, Riese H, Penninx BWJH, Giltay EJ, et al. Comorbidity between
depression and anxiety: assessing the role of bridge mental states in dynamic psychological networks.
BMC Medicine. 2020; 18(1):308. https://doi.org/10.1186/s12916-020-01738-z PMID: 32988400
7.
Keller MC, Neale MC, Kendler KS. Association of different adverse life events with distinct patterns of
depressive symptoms. The American journal of psychiatry. 2007; 164(10):1521–9; quiz 622. Epub
2007/09/28. https://doi.org/10.1176/appi.ajp.2007.06091564 PMID: 17898343.
8.
Kaufman J, Yang B-Z, Douglas-Palumberi H, Grasso D, Lipschitz D, Houshyar S, et al. Brain-Derived
Neurotrophic Factor–5-HTTLPR Gene Interactions and Environmental Modifiers of Depression in Children. Biological psychiatry. 2006; 59(8):673–80. https://doi.org/10.1016/j.biopsych.2005.10.026 PMID:
16458264
9.
Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology. 2005; 52(2):90–110. https://doi.org/10.1159/
000087097 PMID: 16037678.
10.
Luo J, Zhang L, Ning N, Jiang H, Yu SY. Neotrofin reverses the effects of chronic unpredictable mild
stress on behavior via regulating BDNF, PSD-95 and synaptophysin expression in rat. Behavioural
brain research. 2013; 253:48–53. https://doi.org/10.1016/j.bbr.2013.07.014 PMID: 23850356
11.
American Psychiatric Association APATFoDSMIV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.
12.
Willner P, Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review
and evaluation. Psychopharmacology. 1997; 134(4):319–29. https://doi.org/10.1007/s002130050456
PMID: 9452163.
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
22 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
13.
Willner P, Muscat R, Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of
depression. Neuroscience and biobehavioral reviews. 1992; 16(4):525–34. https://doi.org/10.1016/
s0149-7634(05)80194-0 PMID: 1480349.
14.
Vitale G, Ruggieri V, Filaferro M, Frigeri C, Alboni S, Tascedda F, et al. Chronic treatment with the
selective NOP receptor antagonist [Nphe1,Arg14,Lys15]N/OFQ-NH2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats. Psychopharmacology.
2009; 207(2):173–89. https://doi.org/10.1007/s00213-009-1646-9 PMID: 19711054
15.
D’Aquila P, Monleon S, Borsini F, Brain P, Willner P. Anti-anhedonic actions of the novel serotonergic
agent flibanserin, a potential rapidly-acting antidepressant. European journal of pharmacology. 1997;
340(2–3):121–32. https://doi.org/10.1016/s0014-2999(97)01412-x PMID: 9537806.
16.
Jindal A, Mahesh R, Bhatt S. Etazolate, a phosphodiesterase 4 inhibitor reverses chronic unpredictable
mild stress-induced depression-like behavior and brain oxidative damage. Pharmacology Biochemistry
and Behavior. 2013; 105(0):63–70. https://doi.org/10.1016/j.pbb.2013.01.020 PMID: 23384434
17.
Duman CH. Chapter One—Models of Depression. In: Gerald L, editor. Vitamins & Hormones. Volume
82: Academic Press; 2010. p. 1–21.
18.
Papp M, Gruca P, Boyer PA, Mocaer E. Effect of agomelatine in the chronic mild stress model of
depression in the rat. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2003; 28(4):694–703. https://doi.org/10.1038/sj.npp.1300091 PMID:
12655314.
19.
Orsetti M, Colella L, Dellarole A, Canonico PL, Ferri S, Ghi P. Effects of chronic administration of olanzapine, amitriptyline, haloperidol or sodium valproate in naive and anhedonic rats. The international
journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum. 2006; 9(4):427–36. https://doi.org/10.1017/S146114570500564X PMID:
15967060.
20.
Przegalinski E, Moryl E, Papp M. The effect of 5-HT1A receptor ligands in a chronic mild stress model
of depression. Neuropharmacology. 1995; 34(10):1305–10. https://doi.org/10.1016/0028-3908(95)
00102-c PMID: 8570028.
21.
Muscat R, Papp M, Willner P. Reversal of stress-induced anhedonia by the atypical antidepressants,
fluoxetine and maprotiline. Psychopharmacology. 1992; 109(4):433–8. https://doi.org/10.1007/
BF02247719 PMID: 1365858.
22.
Moreau JL, Jenck F, Martin JR, Perrin S, Haefely WE. Effects of repeated mild stress and two antidepressant treatments on the behavioral response to 5HT1C receptor activation in rats. Psychopharmacology. 1993; 110(1–2):140–4. https://doi.org/10.1007/BF02246963 PMID: 7870874.
23.
Papp M, Moryl E, Willner P. Pharmacological validation of the chronic mild stress model of depression.
European journal of pharmacology. 1996; 296(2):129–36. https://doi.org/10.1016/0014-2999(95)
00697-4 PMID: 8838448.
24.
van der Watt G, Laugharne J, Janca A. Complementary and alternative medicine in the treatment of
anxiety and depression. Current Opinion in Psychiatry. 2008; 21(1):37–42 https://doi.org/10.1097/YCO.
0b013e3282f2d814 PMID: 18281839
25.
Zhang L, Luo J, Zhang M, Yao W, Ma X, Yu SY. Effects of curcumin on chronic, unpredictable, mild,
stress-induced depressive-like behaviour and structural plasticity in the lateral amygdala of rats. The
international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum. 2014:1–14. https://doi.org/10.1017/S1461145713001661 PMID:
24405689.
26.
Zhu KY, Mao QQ, Ip SP, Choi RC, Dong TT, Lau DT, et al. A standardized chinese herbal decoction,
kai-xin-san, restores decreased levels of neurotransmitters and neurotrophic factors in the brain of
chronic stress-induced depressive rats. Evidence-based complementary and alternative medicine:
eCAM. 2012; 2012:149256. https://doi.org/10.1155/2012/149256 PMID: 22973399
27.
Ye L, Hu Z, Du G, Zhang J, Dong Q, Fu F, et al. Antidepressant-like effects of the extract from Cimicifuga foetida L. Journal of ethnopharmacology. 2012; 144(3):683–91. https://doi.org/10.1016/j.jep.2012.
10.013 PMID: 23069943.
28.
Burkill HM. The useful plants of west tropical Africa. 1985;Vol 1.
29.
Adongo DW, Kukuia KKE, Mante PK, Ameyaw EO, Woode E. Antidepressant-Like Effect of the Leaves
of Pseudospondias microcarpa in Mice: Evidence for the Involvement of the Serotoninergic System,
NMDA Receptor Complex, and Nitric Oxide Pathway. BioMed Research International. 2015; 2015:15.
https://doi.org/10.1155/2015/397943 PMID: 26539489
30.
Adongo DW, Mante PK, Kukuia KKE, Woode E. Preclinical evidence of a rapid-onset antidepressantlike effect of Pseudospondias microcarpa hydroethanolic leaf extract in a chronic depression model.
International Journal of Basic & Clinical Pharmacology. 2016; 5(4):1254–62.
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
23 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
31.
NRC. Guide for the Care and Use of Laboratory Animals. Washington (DC): National Academies
Press (US); 2010.
32.
Piato ÂL, Detanico BC, Jesus JF, Lhullier FLR, Nunes DS, Elisabetsky E. Effects of Marapuama in the
chronic mild stress model: Further indication of antidepressant properties. J Ethnopharmacol. 2008;
118(2):300–4. http://dx.doi.org/10.1016/j.jep.2008.04.018 PMID: 18513902
33.
Kalueff AV, Tuohimaa P. Grooming analysis algorithm for neurobehavioural stress research. Brain
Research Protocols. 2004; 13(3):151–8. http://dx.doi.org/10.1016/j.brainresprot.2004.04.002 PMID:
15296852
34.
Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl). 1985; 85: 367–70. https://doi.org/10.1007/BF00428203
PMID: 3923523
35.
Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants.
Arch Int Pharmacodyn Ther. 1977; 229:327–36. PMID: 596982
36.
Nirmal J, Babu CS, Harisudhan T, Ramanathan M. Evaluation of behavioural and antioxidant activity of
Cytisus scoparius Link in rats exposed to chronic unpredictable mild stress. BMC complementary and
alternative medicine. 2008; 8:15. https://doi.org/10.1186/1472-6882-8-15 PMID: 18435835
37.
Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl). 1987;
92(2):180–5. Epub 1987/01/01. https://doi.org/10.1007/BF00177912 PMID: 3110839.
38.
Bodnoff SR, Suranyi-Cadotte B, Quirion R, Meaney MJ. A comparison of the effects of diazepam versus
several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology.
1989; 97(2):277–9. Epub 1989/01/01. https://doi.org/10.1007/BF00442264 PMID: 2567028.
39.
Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of
learning and memory. Nat Protocols. 2006; 1(2):848–58. https://doi.org/10.1038/nprot.2006.116 PMID:
17406317
40.
Dhingra D, Parle M, Kulkarni SK. Memory enhancing activity of Glycyrrhiza glabra in mice. J Ethnopharmacol. 2004; 91(2–3):361–5. Epub 2004/05/04. https://doi.org/10.1016/j.jep.2004.01.016 PMID:
15120462.
41.
Singh N, Parle M. Sildenafil improves acquisition and retention of memory in mice. Indian J Physiol
Pharmacol. 2003; 47(3):318–24. Epub 2004/01/16. PMID: 14723318.
42.
Kumar B, Kuhad A, Chopra K. Neuropsychopharmacological effect of sesamol in unpredictable chronic
mild stress model of depression: behavioral and biochemical evidences. Psychopharmacology. 2011;
214(4):819–28. https://doi.org/10.1007/s00213-010-2094-2 PMID: 21103863
43.
Wiborg O. Chronic mild stress for modeling anhedonia. Cell and tissue research. 2013; 354(1):155–69.
https://doi.org/10.1007/s00441-013-1664-0 PMID: 23801433
44.
Bessa JM, Mesquita AR, Oliveira M, Pego JM, Cerqueira JJ, Palha JA, et al. A trans-dimensional
approach to the behavioral aspects of depression. Frontiers in behavioral neuroscience. 2009; 3:1.
https://doi.org/10.3389/neuro.08.001.2009 PMID: 19194528
45.
Strekalova T, Gorenkova N, Schunk E, Dolgov O, Bartsch D. Selective effects of citalopram in a mouse
model of stress-induced anhedonia with a control for chronic stress. Behav Pharmacol. 2006; 17
(3):271–87. https://doi.org/10.1097/00008877-200605000-00008 PMID: 16572005
46.
Zhu WL, Wang SJ, Liu MM, Shi HS, Zhang RX, Liu JF, et al. Glycine site N-methyl-D-aspartate receptor
antagonist 7-CTKA produces rapid antidepressant-like effects in male rats. Journal of psychiatry & neuroscience: JPN. 2013; 38(5):306–16. https://doi.org/10.1503/jpn.120228 PMID: 23611177
47.
Shin IJ, Son SU, Park H, Kim Y, Park SH, Swanberg K, et al. Preclinical evidence of rapid-onset antidepressant-like effect in Radix Polygalae extract. PloS one. 2014; 9(2):e88617. Epub 2014/02/13. https://
doi.org/10.1371/journal.pone.0088617 PMID: 24520403
48.
Smolinsky A, Bergner C, LaPorte J, Kalueff A. Analysis of Grooming Behavior and Its Utility in Studying
Animal Stress, Anxiety, and Depression. In: Gould TD, editor. Mood and Anxiety Related Phenotypes in
Mice. Neuromethods. 42: Humana Press; 2009. p. 21–36.
49.
Ducottet C, Griebel G, Belzung C. Effects of the selective nonpeptide corticotropin-releasing factor
receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2003; 27(4):625–31. https://doi.org/10.1016/S0278-5846(03)00051-4
PMID: 12787849
50.
Detanico BC, Piato ÂL, Freitas JJ, Lhullier FL, Hidalgo MP, Caumo W, et al. Antidepressant-like effects
of melatonin in the mouse chronic mild stress model. European journal of pharmacology. 2009; 607(1–
3):121–5. http://dx.doi.org/10.1016/j.ejphar.2009.02.037 PMID: 19249298
51.
Nutt DJ. Overview of diagnosis and drug treatments of anxiety disorders. CNS spectrums. 2005; 10
(1):49–56. Epub 2004/12/25. https://doi.org/10.1017/s1092852900009901 PMID: 15618947.
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
24 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
52.
Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA, et al. The mood-improving actions of
antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Molecular psychiatry. 2009; 14(8):764–73, 39. https://doi.org/10.1038/mp.2008.119 PMID: 18982002.
53.
Ma X-c, Jiang D, Jiang W-h, Wang F, Jia M, Wu J, et al. Social Isolation-Induced Aggression Potentiates Anxiety and Depressive-Like Behavior in Male Mice Subjected to Unpredictable Chronic Mild
Stress. PloS one. 2011; 6(6):e20955. https://doi.org/10.1371/journal.pone.0020955 PMID: 21698062
54.
Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003; 463(1–3):3–33. https://doi.org/10.1016/s0014-2999(03)01272-x
PMID: 12600700
55.
Dulawa SC, Holick KA, Gundersen B, Hen R. Effects of Chronic Fluoxetine in Animal Models of Anxiety
and Depression. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2004; 29(7):1321–30. https://doi.org/10.1038/sj.npp.1300433 PMID: 15085085
56.
Mattioli L, Funari C, Perfumi M. Effects of Rhodiola rosea L. extract on behavioural and physiological
alterations induced by chronic mild stress in female rats. Journal of psychopharmacology. 2009; 23
(2):130–42. https://doi.org/10.1177/0269881108089872 PMID: 18515456.
57.
Wang SH, Zhang ZJ, Guo YJ, Zhou H, Teng GJ, Chen BA. Anhedonia and activity deficits in rats:
impact of post-stroke depression. Journal of psychopharmacology. 2009; 23(3):295–304. https://doi.
org/10.1177/0269881108089814 PMID: 18562439.
58.
Adongo DW, Mante PK, Kukuia E, Kwami K, Ameyaw EO, Woode E, et al. Anxiolytic-like effect of the
leaves of Pseudospondias microcarpa (A. Rich.) Engl. in mice. Journal of basic and clinical physiology
and pharmacology. 2016; 27(5):533–46. https://doi.org/10.1515/jbcpp-2015-0067 PMID: 27124674
59.
File SE. Factors controlling measures of anxiety and responses to novelty in the mouse. Behavioural
Brain Research. 2001; 125(1–2):151–7. https://doi.org/10.1016/s0166-4328(01)00292-3 PMID:
11682106
60.
Rodgers RJ. Animal Tests for Anxiety. In: Editors-in-Chief: George FK, Michel Le M, Richard F. ThompsonA2—Editors-in-Chief: Koob George F. MLM, Richard FT, editors. Encyclopedia of Behavioral Neuroscience. Oxford: Academic Press; 2010. p. 90–100.
61.
Griebel G, Simiand J, Serradeil-Le Gal C, Wagnon J, Pascal M, Scatton B, et al. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an
innovative approach for the treatment of stress-related disorders. Proceedings of the National Academy
of Sciences of the United States of America. 2002; 99(9):6370–5. https://doi.org/10.1073/pnas.
092012099 PMID: 11959912
62.
Maslova LN, Bulygina VV, Markel AL. Chronic stress during prepubertal development: immediate and
long-lasting effects on arterial blood pressure and anxiety-related behavior. Psychoneuroendocrinology. 2002; 27(5):549–61. https://doi.org/10.1016/s0306-4530(01)00092-0 PMID: 11965354.
63.
Carobrez AP, Bertoglio LJ. Ethological and temporal analyses of anxiety-like behavior: the elevated
plus-maze model 20 years on. Neurosci Biobehav Rev. 2005; 29(8):1193–205. Epub 2005/08/09.
https://doi.org/10.1016/j.neubiorev.2005.04.017 PMID: 16084592.
64.
Spiacci A Jr, Kanamaru F, Guimarães FS, Oliveira RMW. Nitric oxide-mediated anxiolytic-like and antidepressant-like effects in animal models of anxiety and depression. Pharmacology Biochemistry and
Behavior. 2008; 88(3):247–55. https://doi.org/10.1016/j.pbb.2007.08.008 PMID: 17915303
65.
Dulawa SC, Hen R. Recent advances in animal models of chronic antidepressant effects: The noveltyinduced hypophagia test. Neuroscience & Biobehavioral Reviews. 2005; 29(4–5):771–83. http://dx.doi.
org/10.1016/j.neubiorev.2005.03.017 PMID: 15890403
66.
Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al. Requirement of Hippocampal
Neurogenesis for the Behavioral Effects of Antidepressants. Science. 2003; 301(5634):805–9. https://
doi.org/10.1126/science.1083328 PMID: 12907793
67.
Zubenko GS, Zubenko WN, McPherson S, Spoor E, Marin DB, Farlow MR, et al. A collaborative study
of the emergence and clinical features of the major depressive syndrome of Alzheimer’s disease. The
American journal of psychiatry. 2003; 160(5):857–66. Epub 2003/05/03. https://doi.org/10.1176/appi.
ajp.160.5.857 PMID: 12727688.
68.
Song L, Che W, Min-wei W, Murakami Y, Matsumoto K. Impairment of the spatial learning and memory
induced by learned helplessness and chronic mild stress. Pharmacology Biochemistry and Behavior.
2006; 83(2):186–93. http://dx.doi.org/10.1016/j.pbb.2006.01.004 PMID: 16519925
69.
Morris RG, Garrud P, Rawlins JN, O’Keefe J. Place navigation impaired in rats with hippocampal
lesions. Nature. 1982; 297(5868):681–3. Epub 1982/06/24. https://doi.org/10.1038/297681a0 PMID:
7088155.
70.
Rossato JI, Zinn CG, Furini C, Bevilaqua LRM, Medina JH, Cammarota M, et al. A link between the hippocampal and the striatal memory systems of the brain. Anais da Academia Brasileira de Ciências.
2006; 78:515–23. https://doi.org/10.1590/s0001-37652006000300011 PMID: 16936940
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
25 / 26
PLOS ONE
Antidepressant effects of Pseudospondias microcarpa hydroethanolic leaf extract in mice
71.
Kenney J, Gould T. Modulation of Hippocampus-Dependent Learning and Synaptic Plasticity by Nicotine. Mol Neurobiol. 2008; 38(1):101–21. https://doi.org/10.1007/s12035-008-8037-9 PMID: 18690555
72.
Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat
Rev Neurosci. 2006; 7(2):137–51. https://doi.org/10.1038/nrn1846 PMID: 16429123
73.
Wang J, Chai A, Zhou Q, Lv L, Wang L, Yang Y, et al. Chronic clomipramine treatment reverses core
symptom of depression in subordinate tree shrews. PloS one. 2013; 8(12):e80980. Epub 2013/12/07.
https://doi.org/10.1371/journal.pone.0080980 PMID: 24312510
74.
Faraday MM. Rat sex and strain differences in responses to stress. Physiol Behav. 2002; 75(4):507–
22. https://doi.org/10.1016/s0031-9384(02)00645-5 PMID: 12062315
75.
Dalla C, Antoniou K, Drossopoulou G, Xagoraris M, Kokras N, Sfikakis A, et al. Chronic mild stress
impact: are females more vulnerable? Neuroscience. 2005; 135(3):703–14. https://doi.org/10.1016/j.
neuroscience.2005.06.068 PMID: 16125862.
76.
Konkle ATM, Baker SL, Kentner AC, Barbagallo LS-M, Merali Z, Bielajew C. Evaluation of the effects of
chronic mild stressors on hedonic and physiological responses: sex and strain compared. Brain
research. 2003; 992(2):227–38. http://dx.doi.org/10.1016/j.brainres.2003.08.047 PMID: 14625061
PLOS ONE | https://doi.org/10.1371/journal.pone.0278231 February 2, 2023
26 / 26